Development and evaluation of the novel topical formulation containing Bakuchiol for enhanced skin delivery

: This study investigates the encapsulation of bakuchiol, a renowned compound for hyperpigmentation treatment, utilizing transfersomes as a delivery system. The transfersomes were fabricated using the thin-film hydration technique and subjected to thorough characterization across various parameters. The resulting transfersome formulation, after optimization, demonstrated notably high encapsulation efficiencies, with bakuchiol registering at 86.7 +/- 3.6%, accompanied by a narrow particle size distribution (179.9 +/- 5.4 nm). In vitro release studies unveiled cumulative release percentages of 71.98 +/- 6.52% for bakuchiol over a 24 -hour period. Ex vivo permeation studies further affirmed heightened retention of bakuchiol within the skin layers compared to control group. Stability assessments indicated that the optimized transfersome remained stable at 5 degrees C for at least 90 days. These findings underscore the remarkable potential of transfersomes in facilitating the delivery of bakuchiol, offering a compelling and viable alternative for hyperpigmentation formulations.